What is the most recent earnings date for OPNT stock?
OPIANT PHARMACEUTICALS INC (OPNT) last reported earnings on 11/14/2022.
OPIANT PHARMACEUTICALS INC (OPNT) Earnings History & Surprises
NASDAQ:OPNT • US6837501039
Current stock price
20.65 USD
-0.12 (-0.58%)
At close:
20.75 USD
+0.1 (+0.48%)
After Hours:
OPNT Earnings overview
Past quarterly earnings results for OPIANT PHARMACEUTICALS INC (OPNT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- N/A
- Period
- Q4 / 2022
- EPS Estimate
- -$1.23
- Revenue Estimate
- 1.836M
Last Reported
Most Recent- Release Date
- Nov 14, 2022
- Period
- Q3 / 2022
- EPS Reported
- -$1.92
- EPS Surprise
- -26.05%
- Revenue Surprise
- -95.37%
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2022 | -1.92 | -1.52 | -26.05% | -442.86% | 173.87K | 3.757M | -95.37% | -98.94% |
| Q2 2022 | -2.31 | -1.39 | -65.91% | -845.16% | 3.894M | 4.748M | -17.98% | -65.41% |
| Q1 2022 | -2.43 | -0.93 | -162.52% | -268.18% | 4.47M | 6.018M | -25.72% | -30.05% |
| Q4 2021 | 0.11 | -0.01 | 1,178.43% | 168.75% | 13.8M | 13.528M | 2.01% | 39.12% |
| Q3 2021 | 0.56 | 0.22 | 157.36% | 273.33% | 16.339M | 12.373M | 32.05% | 79.35% |
| Q2 2021 | 0.31 | -0.29 | 208.54% | 720.00% | 11.259M | 8.366M | 34.58% | 78.44% |
| Q1 2021 | -0.66 | -0.72 | 8.86% | -65.00% | 6.39M | 5.396M | 18.42% | 49.30% |
| Q4 2020 | -0.16 | 0.07 | -313.91% | - | 9.92M | 9.384M | 5.71% | - |
| Q3 2020 | 0.15 | -0.21 | 171.16% | - | 9.11M | 7.913M | 15.13% | - |
| Q2 2020 | -0.05 | -0.25 | 79.85% | - | 6.31M | 6.197M | 1.82% | - |
| Q1 2020 | -0.40 | -0.20 | -102.84% | - | 4.28M | 4.947M | -13.48% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
230.99%
Max EPS beat (4)
1,178.43%
Min EPS beat (4)
-162.52%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-34.27%
Max Revenue beat (4)
2.01%
Min Revenue beat (4)
-95.37%
Analysis
In the last 4 quarters, OPNT has beaten EPS estimates in 1 out of 4 releases
OPNT has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, OPNT has beaten the EPS estimates by 231.0% on average.
In the last 4 quarters, OPNT reported -34.3% below the revenue estimates on average.
Related analysis
OPIANT PHARMACEUTICALS INC / OPNT Earnings FAQ
Did OPIANT PHARMACEUTICALS INC (OPNT) beat earnings estimates last quarter?
OPIANT PHARMACEUTICALS INC (OPNT) missed EPS estimates and missed revenue estimates in the most recent quarter.
How often does OPIANT PHARMACEUTICALS INC (OPNT) beat earnings estimates?
In the last 4 quarters, OPIANT PHARMACEUTICALS INC (OPNT) has beaten EPS estimates in 1 out of 4 releases.